Introduction Coronavirus disease 2019 (COVID-19) pneumonia is associated to systemic
hyper-inflammation and abnormal coagulation profile. D-dimer elevation is particularly frequent…

Background Pirfenidone, a pleiotropic anti-fibrotic treatment, has been shown to slow down
disease progression of idiopathic pulmonary fibrosis (IPF), a fatal and devastating lung …

Idiopathic pulmonary fibrosis (IPF) is characterized by an aberrant repair response with
uncontrolled turnover of extracellular matrix involving mesenchymal cell phenotypes, where lung …

Background Portopulmonary hypertension (PoPH) is a rare condition with poorer survival
compared to idiopathic/familial pulmonary arterial hypertension (IPAH/FPAH). Aims To …

Background and objective The abnormal shortening of telomeres is a mechanism linking
ageing to idiopathic pulmonary fibrosis (IPF) that could be useful in the clinical setting. The …

Idiopathic pulmonary fibrosis (IPF) is a chronic disease mainly associated with aging and, to
date, its causes are still largely unknown. It has been shown that dietary habits can …

Rationale Abnormal values of hypercoagulability biomarkers, such as D-dimer, have been
described in Coronavirus Disease 2019 (COVID-19), which has also been associated with …

The airborne route is the dominant form of COVID‐19 transmission, and therefore, the
development of methodologies to quantify SARS‐CoV‐2 in bioaerosols is needed. We aimed to …

Lung-resident mesenchymal stem cells (LR-MSC) are thought to participate in idiopathic
pulmonary fibrosis (IPF) by differentiating into myofibroblasts. On the other hand, LR-MSC in …

Introduction Statins may have pleiotropic effects in COPD, but mechanisms remain unclear.
Objectives To assess the pleiotropic effect of statins in patients with stable COPD on (1): lung …